{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:59:07Z","timestamp":1771549147012,"version":"3.50.1"},"reference-count":73,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Technetium-99m bone scintigraphy has revolutionized the non-invasive diagnosis of transthyretin cardiac amyloidosis (ATTR-CM) and markedly increased disease recognition. Although this technique should ideally be applied in patients with a high pre-test probability of ATTR-CM, its use in other clinical settings may reveal incidental pathological myocardial uptake that prompts referral to specialized centers even in the absence of typical red flags. In such cases, where confounding factors such as left ventricular hypertrophy from alternative causes may coexist, awareness of potential pitfalls and the integration of scintigraphic findings with clinical features, biomarkers, and echocardiographic data are essential to avoid misdiagnosis and inappropriate therapy. Cardiac magnetic resonance (CMR) imaging provides a crucial complementary role, offering refined tissue characterization, improved differential diagnosis, and valuable prognostic insights. A combined approach that situates scintigraphy within the broader clinical context and incorporates CMR in ambiguous cases is fundamental to ensure an accurate diagnosis and optimal patient management.<\/jats:p>","DOI":"10.3390\/jcm14238458","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:30:07Z","timestamp":1765207807000},"page":"8458","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-Invasive Diagnostic Algorithm in Transthyretin Cardiac Amyloidosis: Is Bone Scintigraphy Always Enough?"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4311-7570","authenticated-orcid":false,"given":"Giulia","family":"Marchionni","sequence":"first","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, Sapienza, University of Rome, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Pecci","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, Sapienza, University of Rome, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Alfarano","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, Sapienza, University of Rome, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Costantino","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, Sapienza, University of Rome, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Ballatore","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, Sapienza, University of Rome, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Ciccarelli","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, Sapienza, University of Rome, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4994-9434","authenticated-orcid":false,"given":"Antonio","family":"Lattanzio","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, Sapienza, University of Rome, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4708-5120","authenticated-orcid":false,"given":"Nicola","family":"Galea","sequence":"additional","affiliation":[{"name":"Department of Radiological, Oncological and Pathological Sciences, Sapienza, University of Rome, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4690-1528","authenticated-orcid":false,"given":"Giuseppe","family":"De Vincentis","sequence":"additional","affiliation":[{"name":"Department of Radiological, Oncological and Pathological Sciences, Sapienza, University of Rome, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Chimenti","sequence":"additional","affiliation":[{"name":"Department of Medical and Cardiovascular Sciences, Sapienza, University of Rome, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular Mechanisms of Amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_3","first-page":"e000029","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2\u2014Evidence Base and Standardized Methods of Imaging","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"JACC"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Rapezzi","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1007\/s12350-023-03297-1","article-title":"Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: Systematic review and meta-analysis","volume":"30","author":"Ahluwalia","year":"2023","journal-title":"J. Nucl. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s10554-023-02840-y","article-title":"Trends in diagnosis of cardiac transthyretin amyloidosis: 3-year analysis of scintigraphic studies: Prevalence of myocardial uptake and its predictor factors","volume":"39","author":"Monte","year":"2023","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s12350-021-02575-0","article-title":"The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy","volume":"28","author":"Bianco","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10554-024-03085-z","article-title":"Detection of cardiac amyloidosis on routine bone scintigraphy: An important gatekeeper role for the nuclear medicine physician","volume":"40","author":"Nebhwani","year":"2024","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e006075","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) Cardiac Amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jcmg.2022.07.008","article-title":"Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis","volume":"16","author":"Ioannou","year":"2023","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jcmg.2018.07.007","article-title":"Relative Left Ventricular Apical Sparing of Longitudinal Strain in Cardiac Amyloidosis: Is it Just Amyloid Infiltration?","volume":"12","author":"Rapezzi","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e006619","DOI":"10.1161\/CIRCHEARTFAILURE.119.006619","article-title":"Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis","volume":"13","author":"Cappelli","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Silvetti, E., Lanza, O., Romeo, F., Martino, A., Fedele, E., Lanzillo, C., Crescenzi, C., Fanisio, F., and Cal\u00f2, L. (2023). The pivotal role of ECG in cardiomyopathies. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1178163"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10741-023-10358-7","article-title":"Electrocardiographic abnormalities in patients with cardiomyopathies","volume":"29","author":"Aimo","year":"2024","journal-title":"Heart Fail. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tcm.2023.02.006","article-title":"Electrocardiographic features and rhythm disorders in cardiac amyloidosis","volume":"34","author":"Martini","year":"2024","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ejhf.2113","article-title":"Use of biomarkers to diagnose and manage cardiac amyloidosis","volume":"23","author":"Castiglione","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11739-022-02958-2","article-title":"Circulating biomarkers in diagnosis and management of cardiac amyloidosis: A review for internist","volume":"17","author":"Perfetto","year":"2022","journal-title":"Intern. Emerg. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Saro, R., Pavan, D., Porcari, A., Sinagra, G., and Mojoli, M. (2023). Lights and Shadows of Clinical Applications of Cardiac Scintigraphy with Bone Tracers in Suspected Amyloidosis. J. Clin. Med., 12.","DOI":"10.20944\/preprints202310.1023.v1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"JACC"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2022.01.036","article-title":"Cardiac microcalcifications in transthyretin (ATTR) amyloidosis","volume":"352","author":"Thelander","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","article-title":"Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: Implications for utilizing nuclear medicine studies to subtype amyloidosis","volume":"25","author":"Stats","year":"2016","journal-title":"Cardiovasc. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","article-title":"99mTc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis","volume":"121","author":"Pilebro","year":"2016","journal-title":"Upsala J. Med. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s12350-018-1235-6","article-title":"Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis","volume":"26","author":"Rapezzi","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s12350-017-1166-7","article-title":"Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis","volume":"26","author":"Sperry","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/13506129.2016.1158160","article-title":"99mTc-DPD scintigraphy as a novel imaging modality for identification of skeletal muscle amyloid deposition in light-chain amyloidosis","volume":"23","author":"Hutt","year":"2016","journal-title":"Amyloid"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis","volume":"26","author":"Singh","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40001-023-01629-y","article-title":"Optimizing cardiac amyloidosis assessment: Utility of 1-h and 3-h 99mTc-PYP imaging","volume":"29","author":"Imakhanova","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gherghe, M., Lazar, A.M., Sterea, M.-C., Spiridon, P.M., Motas, N., Gales, L.N., Coriu, D., Badelita, S.N., and Mutuleanu, M.-D. (2023). Quantitative SPECT\/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis\u2014A New Dimension of Molecular Imaging. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10060242"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12350-022-02960-3","article-title":"Quantitative 99mTc-DPD-SPECT\/CT assessment of cardiac amyloidosis","volume":"30","author":"Kessler","year":"2023","journal-title":"J. Nucl. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1007\/s00259-025-07294-z","article-title":"A quantitative SPECT\/CT metric for diagnosing transthyretin cardiac amyloidosis: Multicenter study on biopsy-confirmed cases","volume":"52","author":"Takaishi","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/wjnm.WJNM_25_20","article-title":"Potential diagnostic pitfalls of bone scintigraphy in transthyretin-related amyloidosis","volume":"19","author":"Meristoudis","year":"2020","journal-title":"World J. Nucl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13506129.2020.1744553","article-title":"The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease","volume":"27","author":"Cantinho","year":"2020","journal-title":"Amyloid"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jcmg.2020.09.023","article-title":"Radionuclide Imaging in the Diagnosis of Transthyretin Cardiac Amyloidosis: Different Sensitivity in Early-Onset V30M Mutation?","volume":"14","author":"Rodrigues","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/13506129.2025.2493688","article-title":"High rate of false negative 99mTc-pyrophosphate scintigraphy scans in patients with Leu58His transthyretin amyloid cardiomyopathy","volume":"32","author":"Rahim","year":"2025","journal-title":"Amyloid"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s13023-024-03401-9","article-title":"A series of cases of transthyretin amyloid cardiomyopathy with negative bone scintigraphy but a confirmed positive endomyocardial biopsy","volume":"19","author":"Fraix","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Martini, N., Rizzo, S., Sarais, C., and Cipriani, A. (2020). Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis. BMC Cardiovasc. Disord., 20.","DOI":"10.1186\/s12872-020-01749-x"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"iii7","DOI":"10.1093\/eurheartjsupp\/suaf036","article-title":"Present and future of endomyocardial biopsy in cardiac amyloidosis","volume":"27","author":"Grasso","year":"2025","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jcmg.2020.09.009","article-title":"Recipe for Success in Transthyretin Cardiomyopathy: Monoclonal Protein Rule Out, SPECT Imaging, and Genetic Testing","volume":"14","author":"Alexander","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2020.08.027","article-title":"Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution","volume":"14","author":"Poterucha","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40658-019-0268-5","article-title":"Towards standardization of absolute SPECT\/CT quantification: A multi-center and multi-vendor phantom study","volume":"6","author":"Peters","year":"2019","journal-title":"EJNMMI Phys."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/RLU.0000000000004981","article-title":"False Positive in [99m Tc]Tc-DPD Scintigraphy for Cardiac Amyloidosis Due to Intravenous Iron Administration","volume":"49","year":"2024","journal-title":"Clin. Nucl. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaccao.2021.06.002","article-title":"Mistaken Identity","volume":"3","author":"Nguyen","year":"2021","journal-title":"JACC Cardio Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/13506129.2012.746938","article-title":"High 99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathy","volume":"20","author":"Quarta","year":"2013","journal-title":"Amyloid"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaccas.2021.02.016","article-title":"Hereditary Apolipoprotein A-I-Associated Cardiac Amyloidosis: Importance of Endomyocardial Biopsy When Suspicion Remains High","volume":"3","author":"Saleem","year":"2021","journal-title":"JACC Case Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1259\/0007-1285-49-577-50","article-title":"Rectilinear scanning in the detection of acute myocardial infarction","volume":"49","author":"Murray","year":"1976","journal-title":"Br. J. Radiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1172\/JCI108421","article-title":"Pathophysiology of technetium-99m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs","volume":"57","author":"Buja","year":"1976","journal-title":"J. Clin. Investig."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/0002-8703(79)90474-5","article-title":"Value and limitations of technetium-99m stannous pyrophosphate in the detection of acute myocardial infarction","volume":"98","author":"Codini","year":"1979","journal-title":"Am. Heart J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1097\/RLU.0000000000005086","article-title":"Mitral Annular Calcification as a Potential False-Positive for Cardiac Amyloidosis in 99m Tc-DPD Scintigraphy Accurately Identified by SPECT\/CT","volume":"49","author":"Nunes","year":"2024","journal-title":"Clin. Nucl. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e010338","DOI":"10.1161\/CIRCHEARTFAILURE.122.010338","article-title":"Nonischemic Cardiomyopathy With Myocardial Calcinosis Masquerading as Cardiac Amyloidosis","volume":"16","author":"Singh","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e007059","DOI":"10.1161\/CIRCIMAGING.117.007059","article-title":"Hydroxychloroquine-Mediated Cardiotoxicity With a False-Positive 99mTechnetium-Labeled Pyrophosphate Scan for Transthyretin-Related Cardiac Amyloidosis","volume":"11","author":"Chang","year":"2018","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic Resonance in Transthyretin Cardiac Amyloidosis","volume":"70","author":"Treibel","year":"2017","journal-title":"JACC"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular Magnetic Resonance in Cardiac Amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10554-012-0042-4","article-title":"Utility of the inversion scout sequence (TI scout) in diagnosing myocardial amyloid infiltration","volume":"29","author":"Pandey","year":"2013","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00392-020-01771-1","article-title":"Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: A multi-centre study","volume":"110","author":"Chatzantonis","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zhao, L., Tian, Z., and Fang, Q. (2016). Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: A systematic review and meta-analysis. BMC Cardiovasc. Disord., 16.","DOI":"10.1186\/s12872-016-0311-6"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","article-title":"Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis","volume":"13","author":"Pan","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"O4","DOI":"10.1186\/1532-429X-16-S1-O4","article-title":"Native T1 mapping in ATTR cardiac amyloidosis\u2014Comparison with AL cardiac amyloidosis\u2014A 200 patient study","volume":"16","author":"Fontana","year":"2014","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ehf2.12511","article-title":"Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: A systematic review and meta-analysis","volume":"6","author":"Brownrigg","year":"2019","journal-title":"ESC Heart Fail."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jcmg.2013.01.011","article-title":"T1 mapping for myocardial extracellular volume measurement by CMR: Bolus only versus primed infusion technique","volume":"6","author":"White","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcmg.2020.07.043","article-title":"Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression","volume":"14","author":"Fontana","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jcmg.2023.02.019","article-title":"Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis with Cardiac Magnetic Resonance Derived Extracellular Volume Mapping","volume":"16","author":"Ioannou","year":"2023","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Patel, R.K., Ioannou, A., Sheikh, A., Razvi, Y., Mansell, J., Martinez-Naharro, A., Knight, D., Kotecha, T., Porcari, A., and Chacko, L. (2025). Transthyretin amyloid cardiomyopathy: Natural history and treatment response assessed by cardiovascular magnetic resonance. Eur. Heart J., ehaf412.","DOI":"10.1093\/eurheartj\/ehaf412"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","author":"Patel","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jcmg.2025.03.014","article-title":"Uncertain Clinical Relevance of Serial Bone Scintigraphy Findings in Treated Transthyretin Amyloid Cardiomyopathy","volume":"18","author":"Razvi","year":"2025","journal-title":"JACC Cardiovasc. Imaging"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/23\/8458\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:48:08Z","timestamp":1765208888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/23\/8458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":73,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["jcm14238458"],"URL":"https:\/\/doi.org\/10.3390\/jcm14238458","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}